Clinical Trial Details
— Status: Recruiting
Administrative data
NCT number |
NCT04870086 |
Other study ID # |
APHP210173 |
Secondary ID |
|
Status |
Recruiting |
Phase |
|
First received |
|
Last updated |
|
Start date |
April 6, 2021 |
Est. completion date |
April 23, 2026 |
Study information
Verified date |
June 2022 |
Source |
Assistance Publique - Hôpitaux de Paris |
Contact |
Florence Tubach, MD, PHD |
Phone |
01 42 16 05 88 |
Email |
florence.tubach[@]aphp.fr |
Is FDA regulated |
No |
Health authority |
|
Study type |
Observational
|
Clinical Trial Summary
ESPERES is a national prospective e-cohort study providing a resource for collecting
information on healthcare workers (HCWs) currently working in France. The overall goal of
ESPERES is to develop the infrastructure necessary to create and engage a community of HCWs
who may be eligible for participation in future research studies. ESPERES is set up to answer
research questions, in the field of prevention for HCWs, prevention for their own health,
that of their relatives, their colleagues, and users of the hospital. These research
questions will be carried out in the context of specific subsequent studies. The first study
that will be carried out is related to prevention against COVID-19, in particular vaccination
against COVID-19 and more broadly on the COVID-19 pandemic.
Description:
The study population will be made up of HCWs. For the purposes of this study, a "healthcare
worker" is defined as an individual who currently works in a setting where individuals
receive healthcare (i.e. individuals do not have to work directly with patients, but may have
any role within a setting where individuals receive healthcare, such as administrative
office, housekeeping, food service, etc.). ESPERES will be offered to all the HCWs of the
Assistance Publique - Hôpitaux de Paris (AP-HP) establishments and to other public or private
health establishments (lucrative or not) in the Ile-De-France region and to establishments in
other French regions, in order to diversify the contexts.
Each participant is self-included and collects his own data via a web interface. This cohort
is open, meaning that eligible people can be included until the end of the study (no limited
inclusion period). This cohort will start in 2021 and is scheduled for an initial duration of
24 months but may be extended as part of amendments.
Participants will be regularly asked to answer online questionnaires lasting at most 20
minutes. The frequency of these questionnaires will not exceed one questionnaire every 2
weeks (and will generally be more spaced out). During their follow-up in the cohort,
participants may be asked, depending on their characteristics, to participate in studies
nested in the cohort.
All data from ESPERES will be gathered in a health data repository. The statistical analyses
planned in the research protocol and those responding to specific subsequent studies nested
in ESPERES and validated by the scientific committee, will be performed by the
pharmaco-epidemiology center (CEPHEPI), under the responsibility of Dr Candice ESTELLAT and
Pr Florence TUBACH. The CEPHEPI is backed by the public health department of the hospital
group Pitié-Salpêtrière - Charles Foix, AP-HP.
A calculation of the sample size is not justified for this study as it aims to answer several
research questions in a cohort. However, a number about 15,000 participants in ESPERES are
expected.